X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (139) 139
hematology (114) 114
female (109) 109
male (107) 107
index medicus (99) 99
adult (98) 98
middle aged (81) 81
adolescent (80) 80
transplantation (67) 67
aged (45) 45
stem cells (42) 42
child (41) 41
oncology (40) 40
treatment outcome (39) 39
retrospective studies (34) 34
transplantation, homologous (34) 34
bone-marrow-transplantation (33) 33
leukemia (33) 33
disease-free survival (31) 31
young adult (31) 31
child, preschool (30) 30
analysis (27) 27
survival analysis (27) 27
bone marrow (26) 26
recurrence (26) 26
adults (25) 25
hematopoietic stem cells (25) 25
stem-cell transplantation (25) 25
survival (25) 25
prognosis (23) 23
chemotherapy (22) 22
hematopoietic stem cell transplantation (22) 22
risk factors (21) 21
therapy (21) 21
unrelated donors (21) 21
versus-host-disease (21) 21
cancer (20) 20
ecology (20) 20
graft vs host disease - prevention & control (20) 20
research (20) 20
stem cell transplantation (20) 20
follow-up studies (19) 19
hematopoietic stem cell transplantation - methods (19) 19
survival rate (18) 18
acute myeloid-leukemia (17) 17
bone marrow transplantation (17) 17
children (17) 17
graft vs host disease - etiology (17) 17
hematologic neoplasms - therapy (17) 17
hematology, oncology and palliative medicine (17) 17
immunology (17) 17
transplantation conditioning - methods (17) 17
acute myeloid leukemia (16) 16
birds (16) 16
care and treatment (16) 16
leukemia, myeloid, acute - therapy (16) 16
precursor cell lymphoblastic leukemia-lymphoma - therapy (16) 16
antineoplastic combined chemotherapy protocols - therapeutic use (15) 15
hematologic malignancies (15) 15
hematopoietic stem cell transplantation - adverse effects (15) 15
infant (15) 15
transplantation, autologous (15) 15
cyclophosphamide (14) 14
medical research (14) 14
recipients (14) 14
life sciences (13) 13
multivariate analysis (13) 13
time factors (13) 13
transplants & implants (13) 13
acute disease (12) 12
graft (12) 12
health aspects (12) 12
incidence (12) 12
leukemia, myeloid, acute - mortality (12) 12
outcomes (12) 12
patients (12) 12
remission (12) 12
remission induction (12) 12
risk (12) 12
acute myelogenous leukemia (11) 11
bone-marrow (11) 11
graft survival (11) 11
leukemia - therapy (11) 11
management (11) 11
mortality (11) 11
precursor cell lymphoblastic leukemia-lymphoma - mortality (11) 11
relapse (11) 11
transplantation conditioning (11) 11
1st complete remission (10) 10
bone-marrow transplantation (10) 10
graft vs host disease - mortality (10) 10
medicine, experimental (10) 10
prospective studies (10) 10
tissue donors (10) 10
abridged index medicus (9) 9
age factors (9) 9
animals (9) 9
blood (9) 9
cord blood stem cell transplantation - adverse effects (9) 9
cytarabine - administration & dosage (9) 9
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Leukemia, ISSN 0887-6924, 07/2019, Volume 33, Issue 7, pp. 1833 - 1834
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2010, Volume 11, Issue 7, pp. 653 - 660
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 15, pp. 1525 - 1536
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2004, Volume 351, Issue 22, pp. 2276 - 2285
Journal Article
Leukemia, ISSN 0887-6924, 02/2019, Volume 33, Issue 2, pp. 285 - 286
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2010, Volume 28, Issue 13, pp. 2227 - 2232
Journal Article
Journal Article
Cancer, ISSN 0008-543X, 03/2017, Volume 123, Issue 5, pp. 824 - 831
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 11/2017, Volume 23, Issue 21, pp. 6478 - 6486
Journal Article
Journal of Hematology and Oncology, ISSN 1756-8722, 05/2017, Volume 10, Issue 1, pp. 113 - 11
Background: Allogenic hematopoietic stem cell transplantation (allo-SCT) is the most effective post-remission treatment for adults with high-risk acute... 
Allogenic stem cell transplantation | Non-TCD haploidentical | Adults | Acute lymphoblastic leukemia | SURVIVAL | BONE-MARROW-TRANSPLANTATION | PERIPHERAL-BLOOD | UNRELATED CORD BLOOD | 1ST COMPLETE REMISSION | CHEMOTHERAPY | THERAPY | ONCOLOGY | POSTTRANSPLANTATION CYCLOPHOSPHAMIDE | OUTCOMES | HEMATOLOGY | HEMATOLOGIC MALIGNANCIES | Graft vs Host Disease - epidemiology | Prognosis | Humans | Middle Aged | Male | Precursor Cell Lymphoblastic Leukemia-Lymphoma - diagnosis | Young Adult | Precursor Cell Lymphoblastic Leukemia-Lymphoma - therapy | Adolescent | Survival Analysis | Adult | Female | Graft vs Host Disease - prevention & control | Aged | Neoplasm Recurrence, Local - epidemiology | Retrospective Studies | Hematopoietic Stem Cell Transplantation - methods | Transplantation Conditioning - methods | Transplantation, Homologous - methods | Graft-versus-host reaction | Transplants & implants | Leukemia | Prophylaxis | Stem cell transplantation | Transplantation | Multivariate analysis | Peripheral blood | Bone marrow | Remission | Antigens | Young adults | Acute lymphatic leukemia | Blood & organ donations | Risk groups | Neutrophils | Lymphatic leukemia | Survival | Hemopoiesis | Cyclophosphamide | Chemotherapy | Thymocytes | Globulins | Medical prognosis | Stem cells | Histocompatibility antigen HLA | Life Sciences
Journal Article
Journal Article
Journal Article